Pharmaceutical market moves serious $

According to the Ministry of Health, the Brazilian pharmaceutical market moves US$28 billion annually [as you will see this is backed strongly by the sale of generics medicines]. It is noted that since 1999 Brazil has accelerated its growth in the production of generic medicines - given the launch of the program in the country. Currently, there are about 540 registered pharmaceutical companies in Brazil, 90 of which are producers of generic medicines.

Generics account for 20.6% of sales in units throughout the Brazilian pharmaceutical market. However, the news clarifies that despite advances in the marketing of generic medicines foreign multinational manufacturing drugs still are more engage in the production of ‘new’ drugs because of the large investment in research they put in [is this a negative criticism?!].

The information continues feeding us with more numbers: as a result of the policy to encourage generic drugs in 2009 this represented 19.2% of the pharmaceutical market in Brazil. Between 2002 and 2009 sales jumped from $ 588 million to $ 4.8 billion.
Companies interested in manufacturing and importing generic drugs in Brazil must meet the basic requirements and this includes the need to registration at the National Health Surveillance Agency (ANVISA) - Resolution No. 135 of May 29, 2003.